Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
about
Multigene testing of moderate-risk genes: be mindful of the missenseIntegrating functional data to prioritize causal variants in statistical fine-mapping studies.Leveraging Functional-Annotation Data in Trans-ethnic Fine-Mapping Studies.Leveraging local ancestry to detect gene-gene interactions in genome-wide data.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersTwo decades after BRCA: setting paradigms in personalized cancer care and preventionSystematic fine-mapping of association with BMI and type 2 diabetes at the FTO locus by integrating results from multiple ethnic groupsGenome-wide association study reveals novel quantitative trait Loci associated with resistance to multiple leaf spot diseases of spring wheat.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Genome-wide association studies identifies seven major regions responsible for iron deficiency chlorosis in soybean (Glycine max).Can genomics help usher schizophrenia into the age of RDoC and DSM-6?Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patientsFine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskPrediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.A spectral approach integrating functional genomic annotations for coding and noncoding variants.Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.Discriminatory power of common genetic variants in personalized breast cancer diagnosis.3D genome organization in health and disease: emerging opportunities in cancer translational medicine.FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes.Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities.Non-coding single nucleotide variants affecting estrogen receptor binding and activityFGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach.Identifying the biological basis of GWAS hits for endometriosis.Strategies for fine-mapping complex traits.FOXA1 defines cancer cell specificity.FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis.Improved methods for multi-trait fine mapping of pleiotropic risk loci.Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
P2860
Q24658557-889942B0-D53F-47AD-8DBB-1F63F883CF37Q30865659-D0EB9F3F-DDF1-4451-8ECB-5B005BEBBA11Q30981389-F157F669-2BBF-4FCC-821F-F93A134535E0Q31010655-1E1E4FB0-3816-4C2B-BEEC-83557A522749Q33614244-0260E5E3-AB9F-4640-B92A-FF64C450FD91Q33820594-745B6B56-4B48-4EA1-8330-7A83F493F220Q33825996-F5A813D6-8A37-479B-9532-482DC9CB665BQ34277240-1A416EA1-8EEF-4844-B8EB-319E356D2D9CQ34903062-DFA9E3DC-36AC-47C9-AC1A-E1E8C4C1868FQ35064451-71766A80-5D18-43A2-95F5-367873077AB8Q35254940-AA0DB78C-3FAF-45B9-835C-B0956D02577BQ35370064-4524630B-54E7-4AF1-912C-902EDB9668E8Q35524465-83624B6B-CED4-42C2-BD8D-BFA4220F28C5Q35781357-CC7B838B-1493-4FAB-90BA-46114AA6BAC8Q36086247-5CDA7B00-49CB-4832-BA1E-BE5717F9B6D5Q36124728-212931D8-E50F-46C0-B7C0-DE81047BBA33Q36169701-3A692A19-A239-4798-AD7E-3B39AB2C43A2Q36248936-A6186DD6-B0D2-4480-90B8-4FAB05CC9B8EQ36356727-BB1DF7AE-0A83-44D4-BE20-E2700919B2DCQ36515609-0C1388CF-6F70-4C09-B039-F8FD423F08AAQ36961082-579F5439-2967-41E6-94C9-E2D197B69857Q36972302-A7BC84B5-AC5B-47FA-AC0D-CD1CCFD8BA98Q37025407-7EE4DD13-FAE5-46A6-8EAE-1907FC1F5B39Q37139660-4DACA334-9700-4775-9A12-7C6CB0D385D2Q37271961-CF089F56-C685-46C7-8A9B-8912C4FEDAA3Q37342144-AC8F3B30-2F12-4A20-BB4C-7B7744BCF583Q37396372-C992302A-755F-41A5-8EB8-29276FEE67CFQ37498825-A1520A62-30C2-4AB1-A465-E77ABC78D916Q37594336-32F2F7B0-B0BC-45D5-9A9C-F07DD91BF26EQ37684672-DF3EB5D8-67C8-417D-89AD-83EB5760F637Q37686157-9681FE2F-4709-42FB-83C4-40B2D3AB2753Q38361348-F4565A22-495F-4474-ADC5-AA82279A6092Q38544247-32A943F5-9741-47A6-A317-1AE95D615F59Q38781895-036BB06D-D9B5-4ECE-AFA0-25F37F624680Q38897689-EA0A65CC-ADB4-468A-9F61-867B735659C6Q39356415-2710EF3C-ED7D-42C4-8B05-C8DF739B0422Q39844032-AD7F5032-A2EB-4515-89AB-65696CBA176FQ40137431-11D75DBE-BA2F-4C03-A905-35368E5A98F1Q41011976-1E3EDAF1-740F-49C3-9759-2E3D8235141EQ46103372-7D92BE5F-E13A-4DFC-8558-972DDCE1EA57
P2860
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@en
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@nl
type
label
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@en
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@nl
prefLabel
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@en
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@nl
P2093
P2860
P50
P1476
Fine-scale mapping of the FGFR ...... rentially bind FOXA1 and E2F1.
@en
P2093
Ann Smeets
Ans M W van den Ouweland
Bernardo Bonanni
Bruce A J Ponder
Carolien H M van Deurzen
Catriona McLean
Cheng-Har Yip
Chia-Ni Hsiung
Chiu-Chen Tseng
P2860
P304
P356
10.1016/J.AJHG.2013.10.026
P407
P50
P577
2013-11-27T00:00:00Z